Inventor
TANG HAIFENG
US35 patents
⚠️ This page may combine multiple inventors who share the name “TANG HAIFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
20 patentsUS8952166B2Feb 10, 2015
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME17 citations92
US7759493B2Jul 20, 2010
Antidiabetic bicyclic compounds
MERCK SHARP & DOHME9 citations79
US9839642B2Dec 12, 2017
Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME3 citations72
US9839629B2Dec 12, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME3 citations72
US9850245B2Dec 26, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations71
US9751881B2Sep 5, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations71
US9604998B2Mar 28, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations71
US9573961B2Feb 21, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME3 citations71
US9018211B2Apr 28, 2015
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME5 citations71
US9708336B2Jul 18, 2017
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME4 citations70
US9951052B2Apr 24, 2018
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations69
US11433055B2Sep 6, 2022
Chromane monobactam compounds for the treatment of bacterial infections
MERCK SHARP & DOHME2 citations62
US11230543B2Jan 25, 2022
Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
MERCK SHARP & DOHME2 citations62
US9206198B2Dec 8, 2015
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME2 citations62
US10407421B2Sep 10, 2019
Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
MERCK SHARP & DOHME1 citations61
US9139585B2Sep 22, 2015
Inhibitors of the Renal Outer Medullary Potassium channel
MERCK SHARP & DOHME2 citations61
US11738010B2Aug 29, 2023
Oxazolidinones as TarO inhibitors
MERCK SHARP & DOHME0 citations59
US11141410B2Oct 12, 2021
Oxazolidinones as taro inhibitors
MERCK SHARP & DOHME0 citations59
US9765074B2Sep 19, 2017
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME1 citations51
US10513518B2Dec 24, 2019
Inhibitors of the renal outer medullary potassium channel
MERCK SHARP & DOHME0 citations39
PASTERNAK ALEXANDER
3 patentsUS8673920B2Mar 18, 2014
Inhibitors of the renal outer medullary potassium channel
PASTERNAK ALEXANDER15 citations81
US9062070B2Jun 23, 2015
Inhibitors of the renal outer medullary potassium channel
PASTERNAK ALEXANDER2 citations59
US9056859B2Jun 16, 2015
Inhibitors of the renal outer medullary potassium channel
PASTERNAK ALEXANDER2 citations59
TANG HAIFENG
3 patentsUS9073882B2Jul 7, 2015
Inhibitors of the renal outer medullary potassium channel
TANG HAIFENG2 citations59
US8999990B2Apr 7, 2015
Inhibitors of the renal outer medullary potassium channel
TANG HAIFENG3 citations57
US8999991B2Apr 7, 2015
Inhibitors of the renal outer medullary potassium channel
TANG HAIFENG1 citations49
ANNAPURNA BIO INC
3 patentsUS11944622B2Apr 2, 2024
Compounds and compositions for treating conditions associated with APJ receptor activity
ANNAPURNA BIO INC0 citations56
US11471455B2Oct 18, 2022
Compounds and compositions for treating conditions associated with APJ receptor activity
ANNAPURNA BIO INC1 citations56
US11724997B2Aug 15, 2023
Compounds and compositions for treating conditions associated with APJ receptor activity
ANNAPURNA BIO INC0 citations46